As of Jul 31
| +0.99 / +2.07%|
The 8 analysts offering 12-month price forecasts for ACADIA Pharmaceuticals Inc have a median target of 43.00, with a high estimate of 50.00 and a low estimate of 38.00. The median estimate represents a -11.90% decrease from the last price of 48.81.
The current consensus among 8 polled investment analysts is to Buy stock in ACADIA Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.